Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records

INTRODUCTION: Preliminary data suggest that dipeptidyl peptidase-4 (DPP-4) inhibitors may reduce microvascular events, but there is a little evidence to support this from adequate real-world studies. This study aimed to compare microvascular outcomes between patients-prescribed vildagliptin and thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolaczynski, Wlodzimierz M., Hankins, Matthew, Ong, Siew H., Richter, Hartmut, Clemens, Andreas, Toussi, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014784/
https://www.ncbi.nlm.nih.gov/pubmed/27262995
http://dx.doi.org/10.1007/s13300-016-0177-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014784/
https://www.ncbi.nlm.nih.gov/pubmed/27262995
http://dx.doi.org/10.1007/s13300-016-0177-8

Ejemplares similares